News List

FDA approves Lilly Reyvow
2019-10-21

Recently, Lilly announced that the US FDA approved the company's development of Reyvow (lasmiditan) tablets, as a tr

The third anti-tb drug was approved by the FDA
2019-09-24

On August 14th, the FDA approved TB Alliance new fluorine-containing anti-tuberculosis drug Pretomanid to form BPaL with

Holiday Notice of Mid-Autumn Festival
2019-09-11

To all departments and all employees:According to the related provisions on national holidays & the actual situation

CPhI North America 2020 in Philadelphia USA Booth#1506
2019-08-26

FluoroPharm will exhibit CPhI North America 2020 in Pennsylvania Convention Center,Philadelphia, PA, USA, May 5-7,2020.O

FDA approves third oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor
2019-08-19

The U.S. Food and Drug Administration today granted accelerated approval to Rozlytrek (entrectinib), a treatment for adu

The 150 millionth chemical substance was born!
2019-08-07

According to the American Chemical and Engineering News (C&EN), the American Chemical Abstracts Service (CAS) regist

FDA approves Novartis Piqray® - the first and only treatment specifically for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer
2019-07-12

Novartis today announced the US Food and Drug Administration (FDA) has approved Piqray® (alpelisib) in combination with

New drug delivery method, FDA approved a new epilepsy treatment
2019-06-29

UCB announced that the USFDA has approved Nayzilam (midazolam) nasal spray for the acute treatment of seizure clusters p

Holiday Notice of Dragon Boat Festival
2019-06-01

To all departments and employees:According to the related national legal & the actual situation of our company, we i

Long-term anti-AIDS, Combination of two schemes submits application
2019-05-29

On April 29, 2019,the anti-AIDS long-acting two-party “cabotegravir + Ripirilin”submitted to the FDA for listing applica